Phase 1 Lupus Nephritis trials recruiting now
All Lupus Nephritis trials, every phase
11
Phase 1 recruiting
Other phases for Lupus Nephritis
Phase 1 Lupus Nephritis trials
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
- RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
- UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
- US Zamto-cel Autoimmune Diseases
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.